United States · FDA National Drug Code directory
Benztropine Mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-142_458c005f-8842-3916-e063-6294a90a93b1
- Product NDC
- 62135-142
- Form
- TABLET
- Composition / generic term
- Benztropine mesylate
- Labeler
- Chartwell RX, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19920123
- Source listing expiry
- 20261231
Source-listed ingredients
- BENZTROPINE MESYLATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (62135-142-01) · 62135-142-01
- 1000 TABLET in 1 BOTTLE, PLASTIC (62135-142-10) · 62135-142-10
- 180 TABLET in 1 BOTTLE, PLASTIC (62135-142-18) · 62135-142-18
- 30 TABLET in 1 BOTTLE, PLASTIC (62135-142-30) · 62135-142-30
- 540 TABLET in 1 BOTTLE, PLASTIC (62135-142-57) · 62135-142-57
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →